Clinical Trial

Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia

Completed Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study was to compare two different anesthesia methods for pain control during panretinal photocoagulation (PRP), a type of laser surgery that treats proliferative diabetic retinopathy (PDR). The study included eyes from patients with diabetes and proliferative diabetic retinopathy who were scheduled to undergo their first PRP session. Participants were split into two groups to receive either peribulbar anesthesia, which is a type of anesthesia injected through the eyelid, or a sham injection with topical anesthesia only. Pain on a numerical scale and vital signs were recorded before and for 15 minutes during PRP. These results were compared between the two groups to determine which method delivers superior pain control.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-08.
Trial Details
NCT Number NCT07640256
Lead Sponsor Asociación para Evitar la Ceguera en México
Conditions Proliferative Diabetic Retinopathy
Enrollment 50 participants
Start Date 2023-07-06
Primary Completion 2024-03-21 (estimated)
Study Completion 2024-06-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-14